Exendin-4 protects murine pancreatic β-cells from free fatty acid-induced apoptosis through PI-3K signaling

Endocrine Research

Volumn 38, Issue 1, 2013, Pages 40-47

  Liu, Libin ^a   Liu, Liang ^a   Wang, Yanping ^a   Wang, Linxi ^a   Lin, Yichuan ^a   Liu, Xiaohong ^a   Liu, Xiaoying ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Akt Bcl 2; Apoptosis; Exendin 4; Free fatty acid; Glucagon like peptide 1; Pancreatic islets cell

Indexed keywords

EXENDIN 4; FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; WORTMANNIN; PROTEIN BAX;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME REGULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL DEATH; DRUG MECHANISM; MIN6 CELL LINE; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; FATTY ACIDS, NONESTERIFIED; INSULIN-SECRETING CELLS; MICE; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; VENOMS;

EID: 84871789580     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2012.713423     Document Type: Article

References (22)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased betacell apoptosis in humans with type 2 diabetes. Diabetes 2003;52(1):102-110.
2. Liu LB, Wang YP, Pan XD, Jiang SY, Chen Z. Exendin-4 protected murine MIN6 pancreatic beta-cells from oxidative stress-induced apoptosis via down-regulation of NF-kappaB-iNOS-NO pathway. Yao Xue Xue Bao 2008;43(7):690-694.
3. Johnson JD, Ahmed NT, Luciani DS, et al. Increased islet apoptosis in Pdx1\+/mice. J Clin Invest 2003;111(8):1147-1160.
4. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv 2005;5(2):94-111.
5. Wang H, Kouri G, Wollheim CB. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci 2005;118(Pt. 17):3905-3915.
6. Santangelo C, Matarrese P, Masella R, et al. Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress. J Mol Endocrinol 2007;38(1-2):147-158.
7. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003;52(3):726-733.
8. Hirota N, Otabe S, Nakayama H, Yuan X, Yamada K. Sequential activation of caspases and synergistic beta-cell cytotoxicity by palmitate and anti-Fas antibodies. Life Sci 2006;79(13):1312-1316.
9. Higa M, Shimabukuro M, Shimajiri Y, Takasu N, Shinjyo T, Inaba T. Protein kinase B/Akt signalling is required for palmitate-induced beta-cell lipotoxicity. Diabetes Obes Metab 2006;8(2):228-233.
10. Blandino-Rosano M, Perez-Arana G, Mellado-Gil JM, Segundo C, Aguilar-Diosdado M. Antiproliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J Mol Endocrinol 2008;41(1):35-44.
11. Wang LX, Wang YP, Chen Z, et al. Exendin-4 protects murine pancreatic beta-cells from dexamethasone-induced apoptosis through PKA and PI-3K signaling. Diabetes Res Clin Pract 2010;90 (3):297-304.
12. Ferdaoussi M, Abdelli S, Yang JY, et al. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 2008;57(5):1205-1215.
13. Kawasaki Y, Harashima S, Sasaki M, et al. Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation. Horm Metab Res 2010;42(5):311-317.
14. Li L, El-Kholy W, Rhodes CJ, Brubaker PL. Glucagon-like peptide-1 protects beta cells from cytokineinduced apoptosis and necrosis: role of protein kinase B. Diabetologia 2005;48(7):1339-1349.
15. Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 50-adenosine monophosphate-dependent protein kinase A-and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 2003;144(4):1444-1455.
16. Li HL, Yu YR, Yu HL, Wang C, Zhang XX. Relationship between peripheral insulin resistance and betacell function in obese subjects. Sichuan Da Xue Xue Bao Yi Xue Ban 2005;36(3):378-381.
17. Wang Y, Wang PY, Takashi K. Chronic effects of different non-esterified fatty acids on pancreatic islets of rats. Endocrine 2006;29(1):169-173.
18. Farilla L, Hui H, Bertolotto C, et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 2002;143(11):4397-4408.
19. Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 2004;47(5):806-815.
20. Wang Q, Li L, Xu E, Wong V, Rhodes C, Brubaker PL. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 2004;47 (3):478-487.
21. Tews D, Werner U, Eckel J. Enhanced protection against cytokine-and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues. Horm Metab Res 2008;40(3):172-180.
22. Ranta F, Avram D, Berchtold S, et al. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes 2006;55(5):1380-1390.